Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

ByCharu Aggarwal, MD, MPH,Taofeek K. Owonikoko, MD, PhD,Charles M. Rudin, MD, PhD,Vivek Subbiah, MD,Jared Weiss, MD

June 27th 2022

Drs Owonikoko and Weiss provide a brief overview of small cell lung cancer and the vital importance of an early diagnosis to improve patient outcomes.

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

ByVivek Subbiah, MD

April 13th 2021

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

Trending on OncLive

FDA Approval Tees Up T-DXd Plus Pertuzumab as a New SOC in HER2+ Breast Cancer

Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM

FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC

NALIRIFOX and FOLFIRINOX Facilitate Personalized Treatment in Metastatic Pancreatic Cancer

Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients With Advanced NSCLC Live Longer